Scope
Description
The following medicines will be included in the tender:- Apremilast; Denosumab; Ferric Carboxymaltose; Pazopanib.
Total value (estimated)
- £15,902,104 excluding VAT
- £19,082,525 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 March 2026 to 29 February 2028
- Possible extension to 28 February 2030
- 4 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKL - Wales
Engagement
Engagement deadline
27 November 2025
Engagement process description
This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).
There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Rachelle Elvin (rachelle.elvin@wales.nhs.uk).
Participation
Particular suitability
- Small and medium-sized enterprises (SME)
- Voluntary, community and social enterprises (VCSE)
Submission
Publication date of tender notice (estimated)
27 November 2025
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS Organisation Data Service: RQF
4-5 Charnwood Court,
Cardiff
CF14 3UZ
United Kingdom
Telephone: +442921501383
Email: jennifer.tresilia@wales.nhs.uk
Website: http://nwssp.nhs.wales/ourservices/procurement-services/
Region: UKL22 - Cardiff and Vale of Glamorgan
Organisation type: Public authority - central government
Devolved regulations that apply: Wales